Boston Partners’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-37,838	Closed	-$64.4K	–	734
2022 Q4	$64.4K	Buy	+37,838	New	+$64.4K	﹤0.01%	685
2013 Q3	–	Sell	-110,350	Closed	-$2.97M	–	714
2013 Q2	$2.97M	Buy	+110,350	New	+$2.97M	0.01%	555